Phospholipids
R07A - Other respiratory system products
ATC R07AA02
Unknown
JFDA label: BLES
Indications
Off-label
- Acquired Immunodeficiency Syndrome
- Anemia, Sickle Cell
- Attention Deficit Disorder with Hyperactivity
- Bipolar Disorder
- Child Development Disorders, Pervasive
- Coronary Artery Disease
- Coronary Disease
- Depressive Disorder
- Depressive Disorder, Major
- Dry Eye Syndromes
- Epilepsy
- Fatty Liver
- Immunologic Deficiency Syndromes
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lung Neoplasms
- Multiple Myeloma
- Nutrition Disorders
- Paraproteinemias
- Periodontitis
- Peripheral Arterial Disease
- Premature Birth
- Renal Insufficiency, Chronic
- Severe Acute Respiratory Syndrome
- Sjogren's Syndrome
- Tobacco Use Disorder
Registered Products (2)
| Brand | Form / strength | Pack | Agent | Citizen (JOD) |
|---|---|---|---|---|
| BLES | Vial 27 mg/1 ml, 176-500 mcg/ml | 5 ml pack varies | ALTHAER DRUG STORE | — |
| BLES | Vial 27 mg/1 ml, 176-500 mcg/ml | 3 ml pack varies | ALTHAER DRUG STORE | — |